AbCellera Biologics' GAAP net income for 2021 was $153.464 million, up 29.1% from $118.918 million in the prior year. Revenue increased 60.9% to $375.203 million from $233.155 million a year earlier.
AbCellera Biologics' GAAP net income for 2021 was $153.464 million, up 29.1% from $118.918 million in the prior year. Revenue increased 60.9% to $375.203 million from $233.155 million a year earlier. 
investors.abcellera.com
English (US) 